SRRK
Scholar Rock Holding Corporation
There isn't enough reported data to score SRRK yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SRRK Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Weak | |
| Unavailable |
SRRK's profitability and cash flow are currently under pressure. There isn't enough data to rate its revenue and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SRRK PE Valuation
SRRK has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SRRK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect SRRK's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SRRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.22 | -$0.05 |
| Q2 2026 | -$3.31 | -$0.38 |
| Q1 2026 | -$3.45 | -$0.90 |
| Q4 2025 | -$3.29 | -$0.82 |
| Q3 2025 | -$3.17 | -$0.82 |
| Q2 2025 | -$2.93 | -$0.71 |
| Q1 2025 | -$2.55 | -$0.46 |
| Q4 2024 | -$2.47 | -$0.48 |
SRRK lost $3.22 per share over the past year, about the same as its loss the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SRRK on earnings quality, reporting a profit while its opponent remains loss making.
SRRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2022 | $33.2M | +605% |
| Q4 2021 | $4M | +18% |
| Q3 2021 | $5.5M | +80% |
| Q2 2021 | $4.6M | +18% |
| Q1 2021 | $4.7M | -6.4% |
| Q4 2020 | $3.4M | -55% |
SRRK's revenue is growing: $570,000 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18607% | N/A |
| Q1 2022 | -21% | +557 points |
| Q4 2021 | -873% | -114 points |
| Q3 2021 | -679% | +99 points |
| Q2 2021 | -659% | -160 points |
| Q1 2021 | -578% | -226 points |
| Q4 2020 | -760% | -597 points |
| Q3 2020 | -778% | N/A |
SRRK's operating margin was −18607% last quarter, down 17948 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over SRRK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over SRRK on profitability, with a higher operating margin.
SRRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$81.9M | -$12.9M |
| Q2 2026 | -$70.3M | +$6.8M |
| Q1 2026 | -$82.2M | -$3.2M |
| Q4 2025 | -$75.5M | -$26M |
| Q3 2025 | -$69M | -$16.5M |
| Q2 2025 | -$77.2M | -$27.9M |
| Q1 2025 | -$78.9M | -$29.1M |
| Q4 2024 | -$49.5M | -$12.2M |
SRRK has burned cash in almost every quarter: −$310M over the past year, against −$275M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over SRRK on cash generation, producing positive trailing cash flow while its opponent burns cash.
SRRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +1.8M shares |
| 1 year | +16% | +18.6M shares |
| 3 years | +64% | +51.8M shares |
| 5 years | +262% | +95.8M shares |
| Available history | +381% | +105M shares |
SRRK has 132M diluted shares, up 16% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over SRRK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
SRRK Net Leverage
SRRK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SRRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 25.9 | Neutral |
SRRK's weekly RSI is 44 (neutral) and its Stochastic is 26 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SRRK PE vs Healthcare Sector
SRRK has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SRRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.1 | 2.2% below |
| 20 week MA | $49.5 | 13% below |
| 50 week MA | $47.5 | 9.2% below |
| 100 week MA | $41.5 | 4.1% above |
| 200 week MA | $27.1 | 59% above |
SRRK has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 59% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SRRK on trend strength, trading above more of its moving averages.
SRRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.0 | $51.5 | +296% |
| 2021 | $51.5 | $25.4 | -51% |
| 2022 | $25.4 | $7.97 | -69% |
| 2023 | $7.97 | $18.8 | +136% |
| 2024 | $18.8 | $44.5 | +136% |
| 2025 | $44.5 | $45.7 | +2.7% |
| 2026 YTD | $45.7 | $43.2 | -5.5% |
SRRK's yearly returns have swung widely, from +296% in 2020 to −69% in 2022. It's down 5.5% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SRRK on returns for 2026, with the stronger performance.